SCYX - SCYNEXIS INC
0.892
-0.007 -0.841%
Share volume: 305,951
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.90
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-06-2024 | 03-12-2025 | 05-15-2025 | 08-13-2025 | 11-05-2025 | 03-04-2026 | |
| Total revenue | 1.373 M | 736.000 K | 660.000 K | 977.000 K | 257.000 K | 1.364 M | 334.000 K | 18.646 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.373 M | 736.000 K | 660.000 K | 977.000 K | 257.000 K | 1.364 M | 334.000 K | 18.646 M | |
| -46.39% | -10.33% | 48.03% | -73.69% | 430.74% | -75.51% | 5,482.63% | |||
| Operating expenses | 10.881 M | 9.973 M | 10.980 M | 9.029 M | 8.867 M | 10.925 M | 8.739 M | 8.144 M | |
| Selling general and admin | 3.669 M | 3.166 M | 2.907 M | 4.716 M | 3.726 M | 3.784 M | 3.287 M | 3.598 M | |
| Research and development | 7.212 M | 6.807 M | 8.073 M | 4.313 M | 5.141 M | 7.141 M | 5.452 M | 4.546 M | |
| Total expenses | 10.881 M | 9.973 M | 10.980 M | 9.029 M | 8.867 M | 10.925 M | 8.739 M | 8.144 M | |
| -8.34% | 10.10% | -17.77% | -1.79% | 23.21% | -20.01% | -6.81% | |||
| Operating income | -9.508 M | -9.237 M | -10.320 M | -8.052 M | -8.610 M | -9.561 M | -8.405 M | 10.502 M | |
| Ebit | -9.508 M | -14.970 M | -3.569 M | -4.603 M | -5.682 M | -7.395 M | -9.045 M | 11.821 M | |
| Pretax income | 942.000 K | -14.458 M | -3.203 M | -4.418 M | -5.391 M | -6.885 M | -8.591 M | 12.258 M | |
| -1,634.82% | -77.85% | 37.93% | 22.02% | 27.71% | 24.78% | -242.68% | |||
| Income tax | 531.000 K | 0.000 | -395.000 K | 15.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 411.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | |||||||||
| Net income | 411.000 K | -14.458 M | -2.808 M | -4.433 M | -5.391 M | -6.885 M | -8.591 M | 12.258 M | |
| -3,617.76% | 80.58% | -57.87% | -21.61% | -27.71% | -24.78% | 242.68% |